CMC Requirements for New Drug Registration in Latin America
ISPE
MAY 9, 2023
In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Published 29 February 2016. Position paper.
52 
Let's personalize your content